Aviceda Therapeutics, Inc. is raising up to $200.0M
Aviceda Therapeutics, Inc.· CAMBRIDGE, US· Biotechnology· Filed Nov 22, 2024
Aviceda Therapeutics, Inc. has announced an offering and is seeking capital. No amount is confirmed as raised. Based in CAMBRIDGE, MASSACHUSETTS, US. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
On the record
- Location
- CAMBRIDGE, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Announced target
- Target amount
- $200.0M
- Filing date
- Nov 22, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 0
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $200.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Reg D offering of up to 200,000,000 USD filed; nothing reported sold yet.”
Automatically indexed from SEC EDGAR Form D · filing dated Nov 22, 2024. Details beyond the filing have not been verified.
Tags
Are you associated with Aviceda Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record